Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Assets Average (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Assets Average data on record, last reported at $690.5 million in Q3 2022.

  • For Q3 2022, Assets Average fell 19.48% year-over-year to $690.5 million; the TTM value through Sep 2022 reached $690.5 million, down 19.48%, while the annual FY2021 figure was $818.3 million, N/A changed from the prior year.
  • Assets Average reached $690.5 million in Q3 2022 per AVIR's latest filing, down from $705.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $857.5 million in Q3 2021 and bottomed at $486.9 million in Q4 2020.
  • Average Assets Average over 3 years is $750.3 million, with a median of $776.6 million recorded in 2021.
  • Peak YoY movement for Assets Average: soared 66.0% in 2021, then decreased 19.48% in 2022.
  • A 3-year view of Assets Average shows it stood at $486.9 million in 2020, then skyrocketed by 66.0% to $808.2 million in 2021, then decreased by 14.57% to $690.5 million in 2022.
  • Per Business Quant database, its latest 3 readings for Assets Average were $690.5 million in Q3 2022, $705.8 million in Q2 2022, and $745.0 million in Q1 2022.